Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

6,777 total articles

Pasithea Therapeutics Announces Appointment of Kartik Krishnan, M.D., Ph.D. as Chief Medical Officer

Pasithea Therapeutics Announces Appointment of Kartik Krishnan, M.D., Ph.D. as Chief Medical Officer

Pasithea Therapeutics, a US-based clinical-stage biotech company, announced the appointment of Kartik Krishnan, M.D., Ph.D., as Chief Medical Officer. Dr. Krishnan brings extensive experience in clinical development, particularly with MEK inhibitors, having contributed to the FDA approval of cobimetinib. He will oversee clinical strategy for PAS-00…

Indivior Announces $175 Million Accelerated Share Repurchase

Indivior Announces $175 Million Accelerated Share Repurchase

Indivior Pharmaceuticals announced a $175 million accelerated share repurchase agreement with Barclays, utilizing part of its ongoing $400 million buyback program. The company aims to demonstrate confidence in its long-term strategy and financial strength without altering prior financial guidance. The ASR will initially repurchase 3.7 million share…

Superior Group of Companies Reports First Quarter 2026 Results

Superior Group of Companies Reports First Quarter 2026 Results

Superior Group of Companies, Inc. reported its Q1 2026 results showing net sales increase to $140.9 million from $137.1 million a year ago, with net income turning positive at $0.8 million compared to a net loss previously. EBITDA rose to $4.8 million. The company confirmed its full-year 2026 sales and earnings outlook with net sales expected betwe…

ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older

ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older

ADMA Biologics announced that the FDA has approved the supplemental Biologics License Application for ASCENIV™, expanding its indication for primary humoral immunodeficiency (PI) to include pediatric patients aged two years and older, down from twelve years. This approval follows the final pediatric assessment study report, fulfilling post-marketin…

SOLV Energy Expands Utility Infrastructure Platform with Roberson Waite Electric Acquisition, Advancing Long-Term Growth Strategy for Shareholders

SOLV Energy Expands Utility Infrastructure Platform with Roberson Waite Electric Acquisition, Advancing Long-Term Growth Strategy for Shareholders

SOLV Energy announced its agreement to acquire Roberson Waite Electric, a California-based utility substation construction and services provider. This acquisition expands SOLV’s capabilities into the regulated utility market, enhancing its service offerings in grid modernization and resilience, and supports its long-term growth strategy.

Centrum Launches Newly Reformulated Adults 50+ Complete Multivitamin with Clinically Shown Cognitive Benefits

Centrum Launches Newly Reformulated Adults 50+ Complete Multivitamin with Clinically Shown Cognitive Benefits

Haleon, a global consumer health leader, has introduced the newly reformulated Centrum Adults 50+ Complete Multivitamin in Canada, designed to support nutritional needs and cognitive health of adults aged 50 and over. The formulation is backed by clinical trials demonstrating memory and brain health benefits, continuing Haleon's commitment to scien…

Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Disease

Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Disease

Seres Therapeutics announced preclinical data supporting SER-603, a novel live biotherapeutic candidate designed to target microbial functions linked to mucosal healing and inflammation in inflammatory bowel disease (IBD). Presented at Digestive Disease Week 2026, the data demonstrate SER-603’s potential for precise modulation of inflammatory pathw…

10 Barrel Brewing Launches Clean Slate and Salty Sips, Expanding RTD Line with Functional N/A and Low-Sugar Cocktails

10 Barrel Brewing Launches Clean Slate and Salty Sips, Expanding RTD Line with Functional N/A and Low-Sugar Cocktails

Tilray's craft beer brand 10 Barrel Brewing introduces two new ready-to-drink cocktails—Clean Slate, a non-alcoholic functional beverage infused with vitamins and natural energizers, and Salty Sips, a low-sugar, low-ABV vodka cocktail. These products target changing consumer preferences towards functional, health-conscious drinks and aim to expand …

Cibus Announces Transfer of Gene-Edited Herbicide Tolerance Traits in Interoc Rice Seeds for Testing and Production

Cibus Announces Transfer of Gene-Edited Herbicide Tolerance Traits in Interoc Rice Seeds for Testing and Production

Cibus, Inc. has transferred gene-edited herbicide tolerance traits in rice to its partner Interoc to begin testing and production, ahead of planned commercialization in Latin America. The collaboration leverages Cibus' rapid trait development technology to address agricultural productivity and sustainability, with further gene-edited traits expecte…

BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema

BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema

BioCryst Pharmaceuticals has entered into an exclusive licensing agreement with Neopharmed Gentili's Irish affiliate granting rights to commercialize navenibart, a Phase 3 investigational treatment for hereditary angioedema, in Europe. The deal includes $70 million upfront, up to $275 million in milestone payments, and tiered royalties, strengtheni…

Bowman Acquires Nevada-based Smith & Associates Land Surveying

Bowman Acquires Nevada-based Smith & Associates Land Surveying

Bowman Consulting Group Ltd. (NASDAQ: BWMN) has acquired Smith & Associates Land Surveying, LLC, a Las Vegas-based land surveying firm with over 30 years of experience. The acquisition enhances Bowman's presence in the growing Southwest U.S. market, adds specialized surveying capabilities, and is expected to contribute approximately $2 million in a…